Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner

Earlier usage of a targeted radionuclide therapy delays metastatic prostate crab progression erstwhile administered arsenic portion of a trio of drugs, according to a Phase III objective proceedings led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators astatine respective different institutions worldwide.